Literature DB >> 18757475

Regulation of matrix metalloproteinases is at the heart of myocardial remodeling.

Scott P Levick, Gregory L Brower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18757475      PMCID： PMC2593525          DOI： 10.1152/ajpheart.907.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN： 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  19 in total

1.  Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

Authors:  R S Vasan; M G Larson; E J Benjamin; J C Evans; D Levy
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

Review 2.  The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Jason D Gardner; Amanda L Chancey; James A Stewart
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

3.  The distribution of collagenase in normal rat tissues.

Authors:  I Montfort; R Pérez-Tamayo
Journal:  J Histochem Cytochem       Date:  1975-12       Impact factor: 2.479

Review 4.  Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.

Authors:  Y Y Li; C F McTiernan; A M Feldman
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

Review 5.  Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction.

Authors:  Jeanine D'Armiento
Journal:  Trends Cardiovasc Med       Date:  2002-04       Impact factor: 6.677

6.  Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload.

Authors:  Amanda L Chancey; Gregory L Brower; J Thomas Peterson; Joseph S Janicki
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

7.  Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.

Authors:  J T Peterson; H Hallak; L Johnson; H Li; P M O'Brien; D R Sliskovic; T M Bocan; M L Coker; T Etoh; F G Spinale
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

8.  A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.

Authors:  F G Spinale; M L Coker; L J Heung; B R Bond; H R Gunasinghe; T Etoh; A T Goldberg; J L Zellner; A J Crumbley
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

9.  TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.

Authors:  William S Bradham; Gordon Moe; Katherine A Wendt; Amelia A Scott; Andrea Konig; Marina Romanova; George Naik; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-04       Impact factor: 4.733

10.  The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily.

Authors:  C Biswas; Y Zhang; R DeCastro; H Guo; T Nakamura; H Kataoka; K Nabeshima
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701
View more
  5 in total

1.  Identification of Adamts4 as a novel adult cardiac injury biomarker with therapeutic implications in patients with cardiac injuries.

Authors:  Riffat Khanam; Arunima Sengupta; Dipankar Mukhopadhyay; Santanu Chakraborty
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

2.  Collagen XIV is important for growth and structural integrity of the myocardium.

Authors:  Ge Tao; Agata K Levay; Jacqueline D Peacock; Danielle J Huk; Sarah N Both; Nicole H Purcell; Jose R Pinto; Maarten L Galantowicz; Manuel Koch; Pamela A Lucchesi; David E Birk; Joy Lincoln
Journal:  J Mol Cell Cardiol       Date:  2012-08-11       Impact factor: 5.000

Review 3.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

4.  Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts.

Authors:  Shao-lei Yi; Xiao-jun Liu; Jing-quan Zhong; Yun Zhang
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

5.  Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.

Authors:  Meijuan Zou; Fang Wang; Rui Gao; Jingjing Wu; Yingwei Ou; Xuguan Chen; Tongshan Wang; Xin Zhou; Wei Zhu; Ping Li; Lian-Wen Qi; Ting Jiang; Weiwei Wang; Chunyu Li; Jun Chen; Qifang He; Yan Chen
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.